Paul Laikind

Paul Laikind, Ph.D., is a seasoned professional in the biotechnology and medical research sectors, currently serving as a Business Advisor at Harness Therapeutics and a board member at Stemson Therapeutics. With an extensive background, Laikind has held significant leadership positions, including former President and CEO at ViaCyte, and has been actively involved with BIOCOM and CONNECT in various capacities since 1998. Laikind's expertise is further demonstrated through roles as President of GVM BioBusiness Consulting and Chief Business Officer at the Sanford-Burnham Medical Research Institute. Educational credentials include a Ph.D. in Biochemistry from UC San Diego and a BS in Biochemistry from the University of California, Davis.